Status:
COMPLETED
Predictors of Neonatal Necrotizing Enterocolitis
Lead Sponsor:
Ain Shams University
Conditions:
Necrotising Enterocolitis
Eligibility:
All Genders
1-30 years
Brief Summary
To assess the value of peripheral blood neutrophil to lymphocyte ratio (NLR), serum levels of γ-Glutamyl transferase (GGT), total serum bilirubin and serum calcium (Ca2+) concentrations for early diag...
Detailed Description
Necrotizing enterocolitis (NEC) is primarily a disease process of the gastrointestinal tract of neonates that results in inflammation and bacterial invasion of the bowel wall. Despite extensive resea...
Eligibility Criteria
Inclusion
- • Patient group: NEC preterm neonates with gestational ages are between 28-36 weeks regardless of birth weight. NEC diagnosis and staging will be according to Bell's staging criteria.
- • Control group: Stable preterm neonate with matched gestational and postnatal ages without infectious diseases will be included.
Exclusion
- Neonates with congenital infectious diseases, perinatal asphyxia, severe birth defects, congenital digestive tract malformations, inherited metabolic diseases or parental refusal of enrollment.
Key Trial Info
Start Date :
June 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 15 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04277533
Start Date
June 15 2019
End Date
February 15 2020
Last Update
August 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams university Faculty of medicine
Cairo, Egypt, 11591